Prices are the maximum retail price (MRP) published by DGDA, shown per strip for tablets and capsules. Prices marked market price are from retail listings where DGDA has not published one.
IndicationsCobicistat is a pharmacokinetic enhancer (booster) used in HIV-1 treatment. It has no activity against HIV itself; it is combined with certain HIV medicines, mainly Darunavir or Atazanavir (and in some combinations Elvitegravir), to raise and prolong their…
IndicationsDarunavir is an antiretroviral medicine used with other HIV medicines to treat HIV-1 infection in adults and children (above a certain age and weight). It must always be taken together with a booster, either Ritonavir or Cobicistat, and…
Registration details and prices come from the public register of the Directorate General of Drug Administration (DGDA). This page is for information and does not replace advice from your doctor or pharmacist.